Flecainide
Articles · Medicine Compliance Aid Stability · Lactation Safety Information · Published , updated
46576005
Articles
6th November 2020
What injections can be given orally or via enteral feeding tubes?
This updated Medicines Q&A is a quick reference summary to different types of enteral feeding tubes, in relation to medication issues. Not all enteral feeding… Acetazolamide Acetylcysteine Aminophylline Amoxicillin Arginine Atropine Benzatropine Calcium folinate Chlorphenamine Clonazepam Clonidine Cyclizine Cyclophosphamide Desferrioxamine Dexamethasone Diazepam Digoxin Dinoprostone Dipyridamole Disopyramide Flecainide Flucloxacillin Glycopyrronium Hydralazine Hydrocortisone Hyoscine butylbromide Hyoscine hydrobromide Ketamine Labetalol Levomepromazine Medicines Safety Medroxyprogesterone Methotrexate Methylprednisolone sodium succinate Metoclopramide Metoprolol Midazolam Mycophenolate mofetil Ondansetron Pentazocine Pethidine Pharmaceutical Stability Phytomenadione Procainamide Procyclidine Propranolol Q&A Ranitidine Sodium bicarbonate Sodium chloride Sodium phenylbutyrate Tranexamic acid Vancomycin Verapamil
23rd March 2020
What are the clinically significant drug interactions with tobacco smoking?
This Medicines Q&A summarises those drug interactions with tobacco smoking that are considered to be most clinically important. Most interactions between drugs and tobacco smoking… Aminophylline Chlorpromazine Clozapine Drug interactions Erlotinib Flecainide Methadone Nicotine Olanzapine Q&A Riociguat Theophylline WarfarinMedicine Compliance Aid Stability
Tambocor · Meda Pharmcaeuticals
Meda Pharmcaeuticals
Tambocor
Tablets 50mg, 100mg
R2 · Red 2 · Drug is not suitable for CAs due to theoretical reasons that cannot be mitigated.
Unsuitable
Product is very hygroscopic and therefore unsuitable for MCA.
9th November 2015
Tambocor XL · Meda Pharmcaeuticals
Meda Pharmcaeuticals
Tambocor XL
Capsules 200mg
R2 · Red 2 · Drug is not suitable for CAs due to theoretical reasons that cannot be mitigated.
Unsuitable
Product is very hygroscopic and therefore unsuitable for MCA.
9th November 2015
Lactation Safety Information
Anti-arrhythmic with suitable action
Limited published evidence of safety
Small to moderate amounts in breast milk
Monitor infant for adverse effects and/or plasma levels
Used in full-term neonates from birth
28th September 2016